Acute myeloid leukaemia in childhood: the costs and benefits of intensive treatment.

Response to treatment and resource implications were compared in two groups of children with acute myeloid leukaemia (AML) treated during consecutive periods. Event-free survival at 5 years improved from 12% (SE 3.4) during 1972-82 (group A) to 45% (SE 6.9) during 1983-87 (group B). The median time...

Full description

Bibliographic Details
Main Authors: Phillips, M, Richards, S, Chessells, J
Format: Journal article
Language:English
Published: 1991